Svar is a Swedish life science company that works to deliver the right answers at the right time to improve patient care and accelerate drug development.
🚨 Join us Oct 21 for a #GoodMorningMeeting with MVA!
Discover how cell-based assays boost functional relevance & regulatory alignment—especially for advanced modalities.
Expert insights & a rapid QC case study from AGC Biologics.
#PotencyAssays#CellBasedAssays#MediconValley
We're proactively aligning with new IVDR standards to keep your trust intact. Count on our innovative team to deliver quality and compliance ahead of the curve. Together, we navigate the future of life science. #IVDR#QualityMatters#IVDR#TrustedPartner#answersinlifescience
The #Complement Amplification Loop holds immense potential for therapeutic targeting. Our latest case study explores the functional assessment of #Properdin and #alternativepathway modulation, offering valuable perspectives from Svar complement experts.
hubs.ly/Q02CcVRV0
Excited to share insights from scientists at Svar Life Science on the Assessment of antibody-mediated CDC induction or activation. Learn about innovative approaches shaping the future of therapeutic antibodies!
hubs.ly/Q02DR-z90#bispecificantibodies#bioassay
Immunogenicity in #AAV therapy can be a significant barrier. iLite® technology provides a robust and reliable solution to assess Neutralizing antibodies (#NAbs) against your unique AAV vector. With proven consistency across different #serotypes.
hubs.ly/Q02DS89x0
We're proud to announce that Wieslab Diagnostic Services has successfully renewed its ISO 15189:2022 certification following SWEDAC's inspection this fall!
hubs.ly/Q033Jb_t0
Discover the potential of #Properdin as a crucial regulator in the complement system’s amplification loop. Our case study delves into innovative methods for assessing Properdin function and its implications for #complement therapeutic development.
hubs.ly/Q02CcWc70
Want to expand your knowledge on the role of the complement system in infectious disease?
Take a deep dive into the #complementsystem and how a better understanding of it can help improve diagnosis and therapy for #infectiousdiseases.
hubs.ly/Q02KydV-0
Our iLite® CDC assay offers a truly reflective CDC cell lysis measurement, developed by our expert scientists to advance therapeutic antibody development. Discover more about its innovative engineering in our editorial article. hubs.ly/Q02DRPnC0#bispecificantibodies
Streamline your antibody characterization with the iLite® #CDC#bioassays. With this assay run your experiments immediately without the hassle of cell thawing, counting, or passaging. Improve your efficiency and accelerate data generation. Learn more: hubs.ly/Q02DSqyX0
Facing issues with neutralizing antibodies in your AAV therapy research? Our iLite® technology is designed to assess NAbs against your specific #AAV vector, offering reliable and consistent results across multiple #serotypes.
hubs.ly/Q02DSb270#Immunogenicity
🎄 Season's Greetings from all of us! 🎄
Thank you to our customers, partners, and team for an amazing year. Wishing you all joy, peace, and prosperity this holiday season. Let's achieve new heights together in 2025!
Happy Holidays! ✨
#HappyHolidays#ThankYou#NewYear2025
Regulatory bodies worldwide increasingly recognize the importance of #complement measurement in ensuring the safety and efficacy of #medicaldevices. The Wieslab functional assays enable reproducible and robust assessment of individual pathways. Learn more!
hubs.ly/Q02DSlZQ0
Exhibition of the week: Complement-Based Drug Development Summit!
Discover Svar's #complement solutions! Explore how we support breakthroughs in ophthalmology, neurology, oncology & more. Meet our experts to accelerate your work in this evolving field.
Learn more about the relevance of antibody-induced Complement‐Dependent Cytotoxicity (CDC) and how to measure the potency of induction or inhibition using advanced functional bioassays. hubs.ly/Q02FlnsZ0